Preliminary results of intraoperative photodynamic therapy with 5-aminolevulinic acid in dogs with prostate carcinoma

Veterinary Journal

Volumn 178, Issue 2, 2008, Pages 202-207

  L'Eplattenier, H F ^a   Klem, B ^b   Teske, E ^a   van Sluijs, F J ^a   van Nimwegen, S A ^a   Kirpensteijn, J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b PhotoCure ASA   (Norway)

Author keywords

ALA; Dog; Intraoperative; Photodynamic therapy; Prostate carcinoma

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; INTERLEUKIN 2; MELOXICAM; NITROFURANTOIN;

ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DYSURIA; LASER SURGERY; MALE; METASTASIS; NEODYMIUM LASER; NONHUMAN; ORCHITIS; PEROPERATIVE CARE; PHOTODYNAMIC THERAPY; POSTOPERATIVE INFECTION; PROSTATE CARCINOMA; PROSTATECTOMY; SURVIVAL TIME; SYSTEMIC THERAPY; URETHRA OBSTRUCTION; URINE INCONTINENCE;

AMINOLEVULINIC ACID; ANIMALS; COMBINED MODALITY THERAPY; DOG DISEASES; DOGS; INTRAOPERATIVE CARE; MALE; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

CANIS FAMILIARIS;

EID: 54449097839     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.08.001     Document Type: Article

References (30)

1. Baumgartner R., Huber R.M., Schulz H., Stepp H., Rick K., Gamarra F., Leberig A., and Roth C. Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. Journal of Photochemistry and Photobiology B: Biology 36 (1996) 169-174
2. Casas A., and Batlle A. Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. Current Medicinal Chemistry - Anticancer Agents 2 (2002) 465-475
3. Cheli R., Addis F., Mortellaro C.M., Fonda D., Andreoni A., and Cubeddu R. Hematoporphyrin derivative photochemotherapy of spontaneous animal tumors: clinical results with optimized drug dose. Cancer Letters 23 (1984) 61-66
4. Cheli R., Addis F., Mortellaro C.M., Fonda D., and Cubeddu R. Photodynamic therapy of spontaneous animal tumors using the active component of hematoporphyrin derivative (DHE) as photosensitizing drug: clinical results. Cancer Letters 38 (1987) 101-105
5. Cooley D.M., and Waters D.J. Tumors of the male reproductive system. In: Withrow S.J., and MacEwen E.G. (Eds). Small Animal Clinical Oncology (2001), Saunders, Philadelphia 478-489
6. Cornell K.K., Bostwick D.G., Cooley D.M., Hall G., Harvey H.J., Hendrick M.J., Pauli B.U., Render J.A., Stoica G., Sweet D.C., and Waters D.J. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases. Prostate 45 (2000) 173-183
7. Damber J.E. Endocrine therapy for prostate cancer. Acta Oncologica 44 (2005) 605-609
8. Damber J.E., and Khatami A. Surgical treatment of localized prostate cancer. Acta Oncologica 44 (2005) 599-604
9. Frimberger A.E., Moore A.S., Cincotta L., Cotter S.M., and Foley J.W. Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer. Clinical Cancer Research 4 (1998) 2207-2218
10. Goldsmid S.E., and Bellenger C.R. Urinary incontinence after prostatectomy in dogs. Veterinary Surgery 20 (1991) 253-256
11. Jacobs T.M., and Rosen G.M. Photodynamic therapy as a treatment for esophageal squamous cell carcinoma in a dog. Journal of the American Animal Hospital Association 36 (2000) 257-261
12. Jankun J., Lilge L., Douplik A., Keck R.W., Pestka M., Szkudlarek M., Stevens P.J., Lee R.J., and Selman S.H. Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy. Journal of Urology 172 (2004) 739-743
13. Jankun J., Keck R.W., Skrzypczak-Jankun E., Lilge L., and Selman S.H. Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy. BJU International 95 (2005) 1237-1244
14. Kennedy J.C., Pottier R.H., and Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. Journal of Photochemistry and Photobiology B: Biology 6 (1990) 143-148
15. Kennedy J.C., Marcus S.L., and Pottier R.H. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. Journal of Clinical Laser Medicine and Surgery 14 (1996) 289-304
16. L'Eplattenier H.F., van Nimwegen S.A., van Sluijs F.J., and Kirpensteijn J. Partial prostatectomy using Nd:YAG laser for management of canine prostate carcinoma. Veterinary Surgery 35 (2006) 406-411
17. Liptak J.M., Brutscher S.P., Monnet E., Dernell W.S., Twedt D.C., Kazmierski K.J., Walter C.U., Mullins M.N., Larue S.M., and Withrow S.J. Transurethral resection in the management of urethral and prostatic neoplasia in 6 dogs. Veterinary Surgery 33 (2004) 505-516
18. Lucroy M.D., Bowles M.H., Higbee R.G., Blaik M.A., Ritchey J.W., and Ridgway T.D. Photodynamic therapy for prostatic carcinoma in a dog. Journal of Veterinary Internal Medicine 17 (2003) 235-237
19. Mann F.A., Barrett R.J., and Henderson R.A. Use of a retained urethral catheter in three dogs with prostatic neoplasia. Veterinary Surgery 21 (1992) 342-347
20. Marti A., Lange N., van den Bergh H., Sedmera D., Jichlinski P., and Kucera P. Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. Journal of Urology 162 (1999) 546-552
21. McCaw D.L., Payne J.T., Pope E.R., West M.K., Tompson R.V., and Tate D. Treatment of canine hemangiopericytomas with photodynamic therapy. Lasers in Surgery and Medicine 29 (2001) 23-26
22. Moore J.V., West C.M., and Whitehurst C. The biology of photodynamic therapy. Physics in Medicine and Biology 42 (1997) 913-935
23. Moore C.M., Hoh I.M., Bown S.G., and Emberton M. Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?. BJU International 96 (2005) 754-758
24. Peng Q., Berg K., Moan J., Kongshaug M., and Nesland J.M. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochemistry and Photobiology 65 (1997) 235-251
25. Perotti C., Casas A., Fukuda H., Sacca P., and Batlle A. ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice. British Journal of Cancer 87 (2002) 790-795
26. Perotti C., Casas A., Fukuda H., Sacca P., and Batlle A. Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution. British Journal of Cancer 88 (2003) 432-437
27. PhotoCure. CureLight BroadBand User Manual.
28. Reeds K.B., Ridgway T.D., Higbee R.G., and Lucroy M.D. Non-coherent light for photodynamic therapy of superficial tumours in animals. Veterinary and Comparative Oncology 2 (2004) 157-163
29. Roberts W.G., Klein M.K., Loomis M., Weldy S., and Berns M.W. Photodynamic therapy of spontaneous cancers in felines, canines, and snakes with chloro-aluminum sulfonated phthalocyanine. Journal of the National Cancer Institute 83 (1991) 18-23
30. Teske E., Naan E.C., van Dijk E.M., Van Garderen E., and Schalken J.A. Canine prostate carcinoma: epidemiological evidence of an increased risk in castrated dogs. Molecular and Cellular Endocrinology 197 (2002) 251-255